Revvityブログ
発見から治療までのイノベーションを促進
Latest
Oligonucleotide drug discovery: its journey through time.
Drug Development
November 5, 2025 - 4 min read
Physiological Model Solutions
Revvity and AIM Biotech collaborate to accelerate 3D biology and drug discovery.
October 16, 2025 -
2 min read
Physiological Model Solutions
How microphysiological systems are transforming cancer drug discovery.
September 23, 2025 -
2 min read
Physiological Model Solutions
Transforming research with organoids and the tools that make it possible.
September 10, 2025 -
2 min read
Physiological Model Solutions, Neuroscience Research
Rethinking Alzheimer’s disease with brain-on-chip technology.
May 13, 2025 -
2 min read
Physiological Model Solutions
Essential characterization techniques for organoid cell models.
April 4, 2025 -
2 min read
Physiological Model Solutions, Cancer
Why you should use 3D cell models for high throughput screening.
October 24, 2024 -
4 min read
Physiological Model Solutions, Automation
Partnering with purpose: collaboration with Australian Organoid Facility.
August 9, 2024 -
3 min read
Physiological Model Solutions, Drug Development
Revolutionizing drug safety: tools reshaping toxicology.
August 6, 2024 -
4 min read
Physiological Model Solutions, Cancer
Integrating live-cell imaging with optimized organoid pipelines for prostate cancer drug testing.
July 24, 2024 -
3 min read
Physiological Model Solutions, Automation
Unlocking the potential of organoids: the power of standardization and automation.
June 24, 2024 -
3 min read
